In the MALDI analysis of peptides and proteins, these analytes
appear as a single species, usually in protonated form, in the linear
TOF mass spectra. MS/MS spectra can be collected, since post-source
decay appears to occur . However, by using a combination of sample
preparation methods and delayed extraction, fragment ions can be
generated in the linear TOF MALDI spectrum due to prompt
fragmentation (PF) in the ion source. If PF can be optimized, then
structural information becomes available from MALDI TOF instruments
that only offer the linear TOF option. More importantly, these
fragment ions can be selected for the PSD experiment, and spectra of
the fragment ions can be obtained. This leads to MSn capabilities
that are not currently available in the MALDI TOF instruments that use
reflectron technology. Consider the PSD spectrum of an intact
protonated peptide molecule. The peptide has many basic sites, so the
PSD spectrum contains fragments from many structural forms of the
precursor. The fragment ions observed reflect preferred sites of
protonation. In contrast, consider PSD on a high mass fragment ion
such as a yn ion, which has a specific structure - with the fragment
peptide protonated at the N-terminus. MS/MS spectra of this ion will
be very different than that of the protonated molecule, yielding
products of charge-remote reactions, similar to those we encounter
when working with charged derivatives. The ability to generate prompt
fragments in the ion source of the MALDI experiment for peptides
offers additional options for obtaining sequence information.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
biological productsbiomedical equipment developmentbiomedical resourcebiotechnologyproteinstechnology /technique development
No Sub Projects information available for 3P41RR000480-28S1 0002
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P41RR000480-28S1 0002
Patents
No Patents information available for 3P41RR000480-28S1 0002
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P41RR000480-28S1 0002
Clinical Studies
No Clinical Studies information available for 3P41RR000480-28S1 0002
News and More
Related News Releases
No news release information available for 3P41RR000480-28S1 0002
History
No Historical information available for 3P41RR000480-28S1 0002
Similar Projects
No Similar Projects information available for 3P41RR000480-28S1 0002